Latest filing published 02 Oct 2026 for Spyre Therapeutics, Inc., €370k.
Filing timeline
BuySaleInsider track record
Heidy King-Jones: trading record in brief
This profile gathers the share dealings of Heidy King-Jones in Spyre Therapeutics, Inc. We count 13 filings; the first trade dates from 1 September 2026 and the latest from 1 October 2026.
No open-market purchase appears, only 10 sales worth €4.5M. Other entries cover 3 option exercises.
The latest filing, published on 2 October 2026, reports an option exercise of €370k in Spyre Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Heidy King-Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 28,933 shares@ US$14.50Common StockSEC:0001636282-26-000119:0
- 400 shares@ US$89.24Common StockSEC:0001636282-26-000119:1
- 16,605 shares@ US$90.35Common StockSEC:0001636282-26-000119:2
- 7,228 shares@ US$91.35Common StockSEC:0001636282-26-000119:3
- 2,100 shares@ US$92.70Common StockSEC:0001636282-26-000119:4
- 2,600 shares@ US$93.46Common StockSEC:0001636282-26-000119:5
- 27,999 shares@ US$14.500.0053% mcap14.0% of flowCommon StockSEC:0001636282-26-000111:0
- 4,845 shares@ US$86.400.0054% mcap14.5% of flowCommon StockSEC:0001636282-26-000111:1
- 16,548 shares@ US$87.200.019% mcap49.9% of flowCommon StockSEC:0001636282-26-000111:2
- 6,206 shares@ US$88.170.0071% mcap18.9% of flowCommon StockSEC:0001636282-26-000111:3
- 400 shares@ US$89.380.0005% mcap1.2% of flowCommon StockSEC:0001636282-26-000111:4
- 400 shares@ US$14.500.0001% mcap0.2% of flowCommon StockSEC:0001636282-26-000111:5
- 400 shares@ US$90.000.0005% mcap1.2% of flowCommon StockSEC:0001636282-26-000111:6
13 of 13 declarations
